Literature DB >> 29454754

Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components.

Chieko Mishima1, Naofumi Kagara2, Jun-Ichiro Ikeda3, Eiichi Morii3, Tomohiro Miyake1, Tomonori Tanei1, Yasuto Naoi1, Masafumi Shimoda1, Kenzo Shimazu1, Seung Jin Kim1, Shinzaburo Noguchi1.   

Abstract

The pathologic feature of intraductal papillomas is defined as a papillary structure composed of a fibrovascular stromal core lined by luminal epithelial cells and myoepithelial cells. We used droplet digital PCR for the mutational analysis of AKT1 (E17K) and PIK3CA (H1047R, E542K, and E545K) in 60 papillomas. AKT1 and PIK3CA mutations were detected in 12 (20%) and 17 (28%) of the papillomas, respectively. In five tumors harboring mutations, mutational analysis of AKT1 or PIK3CA was performed separately using luminal epithelial cells and myoepithelial cells sorted using anti-cytokeratin 19 antibody and anti-α smooth muscle actin antibody. The two types of cells from a given papilloma had the identical mutation. Three patients with the PIK3CA mutation-positive papilloma developed breast cancers at the resection site of the papilloma, but none of these subsequent breast cancers had the PIK3CA mutation. These results indicate that a papilloma stems from a bipotent progenitor cell that contains the AKT1 or PIK3CA mutation and proliferates and differentiates to form the papilloma. Papilloma can be a risk factor for developing breast cancer but is unlikely to be its obligate precursor.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29454754     DOI: 10.1016/j.ajpath.2018.01.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  5 in total

1.  The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma.

Authors:  Ian G Campbell; Kylie L Gorringe; Tanjina Kader; Kenneth Elder; Magnus Zethoven; Timothy Semple; Prue Hill; David L Goode; Niko Thio; Dane Cheasley; Simone M Rowley; David J Byrne; Jia-Min Pang; Islam M Miligy; Andrew R Green; Emad A Rakha; Stephen B Fox; G Bruce Mann
Journal:  NPJ Breast Cancer       Date:  2020-03-12

Review 2.  Papillary neoplasms of the breast-reviewing the spectrum.

Authors:  Timothy Kwang Yong Tay; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-01-18       Impact factor: 7.842

3.  Next-generation sequencing revealed recurrent ZFPM1 mutations in encapsulated papillary carcinoma of the breast.

Authors:  Xuguang Liu; Xin Huang; Yan Bai; Zhiwen Zhang; Tiefeng Jin; Huanwen Wu; Zhiyong Liang
Journal:  NPJ Precis Oncol       Date:  2021-05-18

4.  The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma.

Authors:  Ian G Campbell; Kylie L Gorringe; Tanjina Kader; Kenneth Elder; Magnus Zethoven; Timothy Semple; Prue Hill; David L Goode; Niko Thio; Dane Cheasley; Simone M Rowley; David J Byrne; Jia-Min Pang; Islam M Miligy; Andrew R Green; Emad A Rakha; Stephen B Fox; G Bruce Mann
Journal:  NPJ Breast Cancer       Date:  2020-03-12

5.  Myoepithelial progenitors as founder cells of hyperplastic human breast lesions upon PIK3CA transformation.

Authors:  Nadine Goldhammer; Jiyoung Kim; René Villadsen; Lone Rønnov-Jessen; Ole William Petersen
Journal:  Commun Biol       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.